Dendrosomal curcumin inhibits metastatic potential of human SW480 colon cancer cells through down-regulation of claudin1, Zeb1 and Hef1-1 gene expression

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 6, 2015, Pages 2473-2481

  Esmatabadi, Mohammad Javad Dehghan ^a   Farhangi, Baharak ^a   Safari, Zahra ^b   Kazerooni, Hanif ^c   Shirzad, Hadi ^a   Zolghadr, Fatemeh ^a   Sadeghizadeh, Majid ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Cellular adhesion; Colorectal cancer; Dendrosomal curcumin; Human SW480 cells; Metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; CLAUDIN 1; CURCUMIN; DRUG CARRIER; HOMEODOMAIN PROTEIN; MESSENGER RNA; NANOCAPSULE; NEDD9 PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; COLONIC NEOPLASMS; DRUG EFFECTS; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CLAUDIN-1; COLONIC NEOPLASMS; CURCUMIN; DRUG CARRIERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; NANOCAPSULES; PHOSPHOPROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84929208802     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.6.2473     Document Type: Article

References (82)

1. Adachi Y, Takeuchi T, Nagayama T, et al (2009). Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett, 583, 430-6.
2. Aggarwal S, Ichikawa H, Takada Y, et al (2006). Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol, 69, 195-206.
3. Aigner K, Dampier B, Descovich L, et al (2007). The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene, 26, 6979-88.
4. Alizadeh AM, Khaniki M, Azizian S, et al (2012). Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin. Eur J Pharmacol, 689, 226-32.
5. Amar S, Ashok S, Punita D (2011). Claudin-1 Up-regulates the repressor ZEB-1 to inhibit ecadherin expression in colon cancer cells. Gastroenterology, 141, 2140-53.
6. Ammon HP, Wahl MA (1991). Pharmacology of curcuma longa. Planta Med, 57, 1-7.
7. Anand P, Kunnumakkara AB, Newman RA, et al (2007). Bioavailability of curcumin: problems and promises. Mol Pharm, 4, 807-18.
8. Anand P, Thomas SG, Kunnumakkara AB (2008). Biological activities of curcumin and its analogues (Congeners) made by man and mother nature. Biochem Pharmacol, 76, 1590-611.
9. Babaei E, Sadeghizadeh M, Hassan ZM, et al (2012). Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo. Intern Immunopharmacol, 12, 226-34.
10. Bharat BA, Shishir S, Yasunari T, et al (2005). Curcumin suppresses the paclitaxel-induced nuclear factor metastasis of human breast cancer in nude mice kb pathway in breast cancer cells and inhibits lung. Clin Cancer Res, 11, 7490-8.
11. Bora-Tatar G, Dayangac-Erden D, Demir AS, et al (2009). Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies. Bioorg Med Chem, 17, 5219-28.
12. Brabletz S, Brabletz T (2010). The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep, 11, 670-7.
13. Chen HC (2005). Boyden chamber assay. Methods Mol Biol, 294, 15-22.
14. Chen ML, Liang LS, Wang XK (2012). miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1. Clin Exp Metastasis, 29, 457-69.
15. Conroy T, Paillot B, Francois E, et al (2005). Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer-a groupe tumeurs digestives of the federation nationale des centres de lutte contre le cancer study. J Clin Oncol, 23, 1228-36.
16. Das T, Sa G, Saha B, et al (2010). Multifocal signal modulation therapy of cancer: ancient weapon, modern targets. Mol Cell Biochem, 336, 85-95.
17. Dastpeyman M, Motamed N, Azadmanesh K, et al (2012). Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of beta1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI. Med Oncol, 29, 2512-8.
18. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC cancerbase No. 10 [Internet]. Lyon, France.
19. Ferrari E, Pignedoli F, Imbriano C (2011). Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. J Med Chem, 54, 8066-77.
20. Gemmill RM, Roche J, Potiron VA, et al (2011). ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett, 300, 66-78.
21. Gou M, Men K, Shi H, et al (2011). Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale, 3, 1558-67.
22. Graham TR, Zhau HE, Odero-Marah VA, et al (2008). Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res, 68, 2479-88.
23. Gulhati P, Bowen KA, Liu J, et al (2011). mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res, 71, 3246-56.
24. Gupta IR, Ryan AK (2010). Claudins: unlocking the code to tight junction function during embryogenesis and in disease. Clin Genet, 77, 314-25.
25. Hlubek F, Spaderna S, Jung A, et al (2004). Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas. Int J Cancer, 108, 321-6.
26. Hong IK (2008). Curcumin inhibition of integrin (a6b4)-dependent breast cancer cell motility and invasion. Cancer Prev Res, 1, 385-91.
27. Hong JH, Ahn KS, Bae E, et al (2006). The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis, 9, 147-52.
28. Huber MA, Kraut N, Beug H (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol, 17, 548-58.
29. Huei WC (2008). Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res, 68, 7428-38.
30. Hynes RO (2002). Integrins: bidirectional, allosteric signaling machines. Cell, 110, 673-87.
31. Izumchenko E, Singh MK, Plotnikova OV, et al (2009). NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res, 69, 7198-206.
32. Jeffery GH, Henry LS, Charles ER (2009). Curcumin blocks CCL2 induced adhesion, motility and invasion, in part, through down-regulation of CCL2 expression and proteolytic activity. Int J Oncol, 34, 1319-27.
33. Ji H, Ramsey MR, Hayes DN, et al (2007). LKB1 modulates lung cancer differentiation and metastasis. Nature, 448, 807-10.
34. Karadag A, Fedarko NS, Fisher LW (2005). Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44. Cancer Res, 65, 11545-52.
35. Khor TO, Keum YS, Lin W, et al (2006). Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res, 66, 613-21.
36. Kim M, Gans JD, Nogueira C, et al (2006). Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell, 125, 1269-81.
37. Kimelman D, Xu W (2006). beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene, 25, 7482-91.
38. Korinek V (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Sci, 275, 1784-7.
39. Ku G, Tan IB, Yau T, et al (2012). Management of colon cancer: resource-stratified guidelines from the Asian oncology summit 2012. Lancet Oncol, 13, 470-81.
40. Kuo ML, Huang TS, Lin JK (1996). Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta, 1317, 95-100.
41. Kushwaha S, Rastogl A, Rai A, et al (2012). Novel drug delivery system for anticancer drug: a review. Intern J Pharm Tech Res, 4, 542-53.
42. Leu TH, Su SL, Chuang YC, et al (2003). Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity. Biochem Pharmacol, 66, 2323-31.
43. Lev AA (2004). Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, downregulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res, 26, 4423-30.
44. Li Y, Bavarva JH, Wang Z, et al (2011). HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene, 30, 2633-43.
45. Liang CC, Park AY, Guan JL (2007). In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc, 2, 329-33.
46. Meiko T, Tatsuhiko T, Motoharu S, et al (2002). Identification of membrane-type matrix metalloproteinase-1 as a target of the b-catenin/Tcf4 complex in human colorectal cancers. Oncogene, 21, 5861-7.
47. Meng W, Takeichi M (2009). Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol, 1, 289-91.
48. Mirgani MT, Isacchi B, Sadeghizadeh M, et al (2014). Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells. Int J Nanomedicine, 9, 403-17.
49. Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-63.
50. Murray DW (2004). Molecular mechanisms of human colorectal cancer metastasis: identification of novel biomarkers. PhD thesis, Dublin City Univers, 7, 4968-3.
51. Myal Y, Leygue E, Blanchard AA (2010). Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers. J Biomed Biotechnol, 2010, 9568-97.
52. Natarajan M, Stewart JE, Golemis EA, et al (2006). HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene, 25, 1721-32.
53. Nobutomo M, Mikio F, Shoichiro T, et al (2001). Involvement of claudin-1 in the-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res, 12, 469-76.
54. Orr WS, Denbo JW, Saab KR (2012). Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition. Surgery, 151, 736-44.
55. Paleos C (2013). Formation of artificial multicompartment vesosome and dendrosome as prospected drug and gene delivery carriers. J Control Release, 170, 141-52.
56. Qin Ly, Li Mn, Ren Wj, et al (2010). Silencing Pin1 suppresses the expression and bioactivity of MMP-9 through NF-κB in colorectal carcinoma SW480 cells. Clin Oncol Cancer Res, 7, 12-7.
57. Qualtrough D, Buda A, Gaffield W, et al (2004). Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment. Int J Cancer, 110, 831-7.
58. Ravindran J, Prasad S, Aggarwal B (2009). Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? Am Assoc Pharmaceutical Scientists, 11, 495-510.
59. Ray S, Chattopadhyay N, Mitra A, et al (2003). Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J Environ Pathol Toxicol Oncol, 22, 49-58.
60. Sadeghizadeh M, Ranjbar B, Damaghi M (2008). Dendrosomes as novel gene porters-III. J Chem Technol Biotechnol, 83, 912-20.
61. Sanchez-Tillo E, de Barrios O, Siles L, et al (2013). ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1. Clin Cancer Res, 19, 1071-82.
62. Sanchez-Tillo E, Siles L, de Barrios O, et al (2011). Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res, 1, 897-912.
63. Sarah JF, Margret BE, Geraldine MON, et al (2002). Dissection of HEF1-dependent functions in motility and transcriptional regulation. J Cell Sci, 115, 99-111.
64. Sarbolouki MN, Sadeghizadeh M, Yaghoobi MM, et al (2000). Dendrosomes: a novel family of vehicles for transfection and therapy. J Chem Technol Biotechnol, 75, 919-22.
65. Schmalhofer O, Brabletz S, Brabletz T (2009). E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev, 28, 151-66.
66. Sebaugh JL (2011). Guidelines for accurate EC50/IC50 estimation. Pharm Stat, 10, 128-34.
67. Seo EY, Kim WK (2011). Red ginseng extract reduced metastasis of colon cancer cells in vitro and in vivo. J Ginseng Res, 35, 315-24.
68. Sita A, Haruyo I, Yasunari T, et al (2006). Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of kinase and akt activation. Mol Pharmacol, 69, 195-206.
69. Spaderna S, Schmalhofer O, Hlubek F, et al (2006). A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology, 131, 830-40.
70. Sporn MB (1997). The War on Cancer: A Review. Ann New York Academy Scie, 833, 137-46.
71. Su CC, Chen, GW, Lin, JG, Wu, LT, Chung, JG (2006a). Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res, 26, 1281-8.
72. Su CC, Lin, JK (2006b). Curcumin-induced apoptosis of human colon cancer Colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3. Anticancer Res, 26, 4379-89.
73. Tian X, Du H, Fu X, et al (2009). Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells. Biochem Biophys Res Commun, 380, 478-83.
74. Trainer DL, Kline T, McCabe FL, et al (1988). Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer, 41, 287-96.
75. Wang G, Wang F, Ding W, et al (2013). APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway. PLoS One, 8, 552-98.
76. Wellner U, Schubert J, Burk UC, et al (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol, 11, 1487-95.
77. Xia Y-Q, Wei1, X-Y, et al (2014). Curcumin analogue A501 induces G2/M arrest and apoptosis in non-small cell lung cancer cells. Asian Pac J Cancer Prev, 15, 6893-8.
78. Xiaofu W, Qingding W, Kirk LI, et al (2006). Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin Cancer Res, 12, 5346-55.
79. Xin ZC (2009). Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Therapy, 8, 1360-8.
80. Yu W, Xu YC, Tao Y, et al (2013). DcR3 regulates the growth and metastatic potential of SW480 colon cancer cells. Oncol Rep, 30, 2741-8.
81. Zhang Z-Y, Dong J-H, Chen Y-W, et al (2012). Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma. Asian Pac J Cancer Prev, 13, 2503-9.
82. Zhao H, Huang A, Li P, et al (2013). E2A suppresses invasion and migration by targeting YAP in colorectal cancer cells. J Transl Med, 11, 317.